Methylphenidate for Apathy in Veterans With Parkinson's Disease

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Parkinson DiseaseApathy
Interventions
BEHAVIORAL

Psychosocial intervention

"The counseling session, in which a trained study clinician will counsel the primary caregiver, will take place at each study visit and after the randomization visit. It will last approximately 20-30 minutes. Each counseling session will consist of the following elements:~* Review and adjustment of the patient and caregiver supportive care plans~* Emotional support and the opportunity to ventilate feelings~* Counseling regarding specific caregiving skills~* Assistance with problem-solving of specific issues that the caregiver brings to the sessions~* Answers to questions regarding the educational materials The educational materials will consist of a copy of the book The 36-Hour Day by Nancy L. Mace and Peter V. Rabins. The caregiver also will be provided with 24-hour phone access to the study nurse or physician for assistance with crises that may arise after hours."

DRUG

Methylphenidate

norepinephrine and dopamine reuptake inhibitor

All Listed Sponsors
lead

Ralph H. Johnson VA Medical Center

FED

NCT05669170 - Methylphenidate for Apathy in Veterans With Parkinson's Disease | Biotech Hunter | Biotech Hunter